Skip to content
10-Q

Quarterly Report

VitaNova Life Sciences Corporation VNOV

0001683168-23-008882

← back to feed
Filed
Dec 15, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Dec 11, 2023 5.87M sh
Current Liabilities Q2 2024 · Oct 31, 2023 $92.22K
Current Liabilities Q2 2024 · Apr 30, 2023 $67.94K
Total Liabilities Q2 2024 · Oct 31, 2023 $92.22K
Total Liabilities Q2 2024 · Apr 30, 2023 $67.94K
Current Assets Q2 2024 · Oct 31, 2023 $0
Current Assets Q2 2024 · Apr 30, 2023 $8.73K
Total Assets Q2 2024 · Oct 31, 2023 $0
Total Assets Q2 2024 · Apr 30, 2023 $8.73K
Shares Diluted Q2 2024 · Oct 31, 2022 5.87M sh
Shares Diluted Q2 2024 · Oct 31, 2022 5.87M sh
Operating Cash Flow Q2 2024 · Oct 31, 2022 $12.09K
Stockholders Equity Q2 2024 · Oct 31, 2022 −$30.25K
Stockholders Equity Q2 2024 · Jul 31, 2022 −$32.85K
Stockholders Equity Q2 2024 · Apr 30, 2022 −$34.99K
Eps Diluted Q2 2024 · Oct 31, 2022 $0.00
Eps Diluted Q2 2024 · Oct 31, 2022 $0.00
Eps Basic Q2 2024 · Oct 31, 2022 $0.00
Eps Basic Q2 2024 · Oct 31, 2022 $0.00
Sga Expense Q2 2024 · Oct 31, 2022 $7.4K
Sga Expense Q2 2024 · Oct 31, 2022 $20.27K
Net Income Q2 2024 · Oct 31, 2022 $2.6K
Net Income Q2 2024 · Oct 31, 2022 $4.74K
Net Income Q2 2024 · Jul 31, 2022 $2.13K